These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10755526)

  • 1. Long-term medical complications in patients surviving > or = 5 years after liver transplant.
    Sheiner PA; Magliocca JF; Bodian CA; Kim-Schluger L; Altaca G; Guarrera JV; Emre S; Fishbein TM; Guy SR; Schwartz ME; Miller CM
    Transplantation; 2000 Mar; 69(5):781-9. PubMed ID: 10755526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation.
    Ciccarelli O; Kaczmarek B; Roggen F; DeReyck C; Goffette P; Danse E; Verbaandert C; Sempoux C; Wittebole X; Wallemacq P; Lerut J
    Acta Gastroenterol Belg; 2005; 68(3):323-30. PubMed ID: 16268419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset cardiovascular risk factors in lung transplant recipients.
    Silverborn M; Jeppsson A; Mårtensson G; Nilsson F
    J Heart Lung Transplant; 2005 Oct; 24(10):1536-43. PubMed ID: 16210127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
    Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
    Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo malignancy post-liver transplantation: a single center, population controlled study.
    Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
    Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity.
    Stegall MD; Everson G; Schroter G; Bilir B; Karrer F; Kam I
    Transplantation; 1995 Nov; 60(9):1057-60. PubMed ID: 7491685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical epidemiology of patients surviving ten years after liver transplantation.
    Simo KA; Sereika S; Bitner N; Newton KN; Gerber DA
    Clin Transplant; 2011; 25(3):360-7. PubMed ID: 20636409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant malignancy in liver transplantation: a single center experience.
    Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
    Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
    Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of adult 20-year survivors after liver transplantation.
    Dopazo C; Bilbao I; Castells LL; Sapisochin G; Moreiras C; Campos-Varela I; Echeverri J; Caralt M; Lázaro JL; Charco R
    Hepatol Int; 2015 Jul; 9(3):461-70. PubMed ID: 25788182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
    Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
    Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
    Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
    Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
    Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
    Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.